American Journal of Clinical Dermatology

Papers
(The H4-Index of American Journal of Clinical Dermatology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Characterization of Clinicopathological Features and Autoantibody Profiles in Patients with Cutaneous Lupus Erythematous: A Single-Center Retrospective Study142
Prognostic Biomarkers in Evolving Melanoma Immunotherapy129
A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis124
Frontal Fibrosing Alopecia: An Update120
Individualized Neoantigen-Directed Melanoma Therapy92
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms89
Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease86
Acknowledgment to Referees84
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review78
Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review75
Tralokinumab for the Treatment of Atopic Dermatitis70
Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”66
Efinaconazole in Onychomycosis66
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study66
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma58
Meat Allergy: A Ticking Time Bomb54
Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments50
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases49
Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma49
Classification and Treatment of Angioedema without Wheals: A Spanish Delphi Consensus46
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”45
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative45
Dapsone Use in Dermatology45
Capturing the Diversity of Dermatology—What’s in a Name?44
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review44
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance44
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study43
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions42
Comment on “Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial”41
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview39
50 Years of Topical Retinoids for Acne: Evolution of Treatment38
Economic Burden of Chronic Hand Eczema: A Review38
Clinical Disease Measures in Generalized Pustular Psoriasis38
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination 36
Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era?35
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety35
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada35
Hypertrophic Scars and Keloids: Advances in Treatment and Review of Established Therapies35
0.045469999313354